Yana Stepanishyna

9PUBLICATIONS
72CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedLiquid biopsiesHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 27, 2025
Efficiency and Safety of Brentuximab Vedotine as a Salvage Treatment Before Autologous Stem Cell Transplantation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: Retrospective Study.

Kateryna Filonenko, Yana Stepanishyna, Nazar Shokun

|Oct 10, 2025
Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study.

Irene Dogliotti, Sanne Tonino, Luana Conte

|May 05, 2025
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study.

Maria Elena Cabrera, Monica Civallero, Yana Stepanishyna

|Apr 03, 2025
High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.

Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

|Apr 09, 2024
Reply to T. Vassilakopoulos et al.

Massimo Federico, Wouter Plattel, Martin Hutchings

Pageof 2

Frequent Collaborators

4 joint publications

Massimo Federico

3 joint publications

Wouter Plattel

3 joint publications

Martin Hutchings

2 joint publications

Caterina Cristinelli